Product image of Okrodin (Octreotide) supplied by GNH India

Okrodin

Active Ingredient:
Octreotide
Origin:
EU

Okrodin (Octreotide)

Octreotide, the active ingredient in Okrodin, is a peptide synthetic analog presented as an injectable solution for subcutaneous use. It is employed to control hormone‑related disorders such as acromegaly and neuroendocrine tumor symptoms in adult patients.
GNH India supplies Okrodin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pharmathen S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Okrodin (octreotide) acts on the somatostatin pathway to manage several endocrine and gastrointestinal conditions.

  • Acromegaly: reduces growth hormone secretion and associated tissue overgrowth.
  • Neuroendocrine tumors: controls hormone‑related flushing and diarrhea.
  • Carcinoid syndrome: diminishes severe flushing and watery diarrhea.
  • VIPoma: alleviates profuse watery diarrhea and electrolyte loss.
  • Acute variceal bleeding: lowers portal pressure to help control bleeding.

How It Works

  • Octreotide mimics natural somatostatin by binding primarily to somatostatin receptor subtype 2 (SSTR2) on target cells, inhibiting the release of growth hormone, insulin, glucagon, and various gastrointestinal peptides, while also reducing splanchnic blood flow and intestinal secretion.

Side Effects

Octreotide may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Abdominal pain: cramping or discomfort.
  • Diarrhea: loose stools, often transient.
  • Injection site reactions: redness or swelling.
  • Hyperglycemia: elevated blood glucose levels.
  • Gallstones: biliary sludge formation.

Serious or Rare Side Effects

  • Severe hyperglycemia or hypoglycemia: requires medical attention.
  • Cardiac arrhythmias: irregular heart rhythms.
  • Acute pancreatitis: sudden abdominal pain with elevated enzymes.
  • Severe allergic reactions: rash, itching, swelling, or anaphylaxis.

Precautions & Warnings

Before initiating Okrodin, consider the following safety measures.

  • Glucose monitoring: assess blood sugar regularly, especially in diabetic patients.
  • Gallbladder evaluation: monitor for biliary sludge or stones during long‑term therapy.
  • Cardiovascular assessment: watch for bradycardia or arrhythmias.
  • Renal function: adjust use in patients with severe renal impairment.
  • Pregnancy and lactation: use only if clearly needed; discuss risks with a healthcare professional.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Octreotide can affect the activity of several concomitant medicines.

Major Interactions (Avoid)

  • Cyclosporine: may increase cyclosporine blood levels, raising toxicity risk.
  • Diazoxide: can diminish octreotide’s glucose‑lowering effect.
  • Bromocriptine: may reduce therapeutic efficacy of octreotide.

Moderate Interactions (Monitor Closely)

  • Insulin and oral hypoglycemics: enhanced hypoglycemic effect; monitor glucose.
  • Other somatostatin analogs: additive hormonal suppression; watch for side effects.
  • Warfarin: potential alteration of anticoagulation; check INR regularly.

Frequently Asked Questions

Okrodin (octreotide) is prescribed for hormone‑related disorders such as acromegaly, symptom control in neuroendocrine tumors, carcinoid syndrome, VIPoma‑induced diarrhea, and acute variceal bleeding. It works by mimicking somatostatin to suppress excess hormone secretion.

Octreotide binds to somatostatin receptors, especially subtype 2, on endocrine and gastrointestinal cells. This binding blocks the release of several hormones—including growth hormone, insulin, and gastrointestinal peptides—and reduces splanchnic blood flow, thereby controlling disease‑related symptoms.

The specific dose of Okrodin is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals tailor the regimen to achieve optimal clinical outcomes while monitoring safety.

Okrodin should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. Clinicians must evaluate each case individually and discuss possible effects with the patient.

To request Okrodin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Okrodin (octreotide) shares the same mechanism as other somatostatin analogs like lanreotide, but differences may exist in formulation, dosing frequency, and approved indications. Clinicians choose based on patient convenience, specific regulatory approvals, and individual response profiles.

Okrodin should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and avoid freezing to maintain stability.

Okrodin is supplied as an injectable solution for subcutaneous (or intravenous) administration. The injection is typically performed by a healthcare professional using aseptic technique, following the dose prescribed by the treating physician.

Serious risks include severe hyperglycemia or hypoglycemia, cardiac arrhythmias, acute pancreatitis, and rare allergic reactions such as anaphylaxis. Patients should be monitored closely for these events, especially during the initiation of therapy.

Okrodin is contraindicated in patients with known hypersensitivity to octreotide or any of its excipients. Caution is advised for individuals with uncontrolled diabetes, severe cardiac conduction disorders, or significant gallbladder disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Octreotide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT